We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Novel Ultrasound Technology Using AI Algorithms Has Potential to Achieve 100 Times Greater Sensitivity

By HospiMedica International staff writers
Posted on 25 Oct 2021

A novel ultrasound technology, using patented hardware, software, and artificial intelligence (AI) algorithms could deliver 100 times higher sensitivity than other ultrasound systems in the market. More...

DeepSight Technology (San Francisco, CA, USA) is augmenting diagnostic medical imaging with the introduction of its novel ultrasound technology that improves ultrasound image quality and more than doubles the effective range when compared to conventional technologies.

DeepSight’s solution incorporates patented hardware, software and AI technologies that vastly improve image quality and extend the depth penetration of medical diagnostic ultrasound - unleashing its full potential. DeepSight imaging solutions are expected to broaden the realm of applications where existing ultrasound technology has been limited and would otherwise require unsafe, more costly and less accessible imaging modalities such as CT or MRI. It aims to improve the speed, range and accuracy of imaging and diagnosis across a range of applications.

Whether for abdominal, breast, or obstetrical applications, there is a need for better image clarity at depths well beyond the range of today’s state-of-the-art scanners. Better sensitivity can help with the identification of masses hard to see with conventional ultrasound. The visualization of tumor structure and blood flow to differentiate between malignant and benign tumors and the ability to accurately assess treatment response can help reduce the need for other diagnostic and interventional methods. DeepSight’s vision is to provide the clarity needed for fast and accurate diagnoses and avoid the need for additional imaging.

"We are excited to be on the frontier of advancing medical imaging," said founder and CEO Nader Sadrzadeh. "Based on internal studies, our technology has the potential to achieve 100 times greater sensitivity, ultimately allowing us to deliver better patient care."

Related Links:
DeepSight Technology 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Masimo smartSET pulse oximetry with PPG AFib and OIRD Detection (Photo courtesy of Masimo)

Smart Pulse Oximetry Supports Earlier Recognition of Arrhythmias and Respiratory Risk

On general care floors, respiratory compromise and arrhythmias can develop between routine checks. Atrial fibrillation often goes undiagnosed in older adults, while opioid-induced respiratory depression... Read more

Surgical Techniques

view channel
Image: A UTSW clinical trial studied a treatment strategy for kidney cancer with inferior vena cava tumor thrombus (IVC-TT) that used targeted radiation on the tumor thrombus followed by surgery to remove the kidney. (Photo courtesy of UT Southwestern)

Targeted Radiotherapy Before Surgery Improves Control of Kidney Cancer Thrombus

Inferior vena cava tumor thrombus occurs when kidney cancer extends into the body’s largest vein, potentially obstructing blood flow, progressing toward the heart, and making surgery more complex.... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.